Enrico Facchiano
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Enrico Facchiano has a total of 137 co-authors. Here are the top co-authors by number of shared publications:
Marcello Lucchese
General and Bariatric Surgery Unit, Department of Surgery, Santa Maria Nuova Hospital, Piazza Santa Maria Nuova, Florence, Italy
17 shared publications- Marcello Lucchese
Azienda Sanitaria Firenze, Santa Maria Nuova Hospital
9 shared publications - Antonio Iannelli
University of Côte d’Azur
8 shared publications Giovanni Quartararo
Department of Surgery, General Metabolic and Bariatric Surgery Unit, Santa Maria Nuova Hospital, Piazza Santa Maria Nuova, Florence, Italy
7 shared publications- Michaela Luconi
Endocrinology Unit, Department of Experimental and Clinical Biomedical Sciences, University of Florence , 50139 Florence
7 shared publications Luca Leuratti
Department of Surgery, General Metabolic and Bariatric Surgery Unit, Santa Maria Nuova Hospital, Piazza Santa Maria Nuova, Florence, Italy
6 shared publications
Latest Publications
- 18 August 2025
- Published by Elsevier in Surgery for Obesity and Related Diseases
- Vol. 21 (11) , 1196-1197
Paired editorial on sleeve to gastric bypass conversion: a multi-institutional study of 217 patients
- 18 August 2025
- Published by Elsevier in Surgery for Obesity and Related Diseases
- Vol. 21 (11) , 1196-1197
Paired editorial on sleeve to gastric bypass conversion: a multi-institutional study of 217 patients
- 14 February 2025
- Published by Elsevier in Surgery for Obesity and Related Diseases
- Vol. 21 (7) , e19-e20
Comment on: Risk assessment for esophageal cancer after bariatric surgery: a comparative cohort study between sleeve gastrectomy and gastric bypass
- 14 February 2025
- Published by Elsevier in Surgery for Obesity and Related Diseases
- Vol. 21 (7) , e19-e20
Comment on: Risk assessment for esophageal cancer after bariatric surgery: a comparative cohort study between sleeve gastrectomy and gastric bypass
- 9 November 2024
- Published by Springer Nature in Updates in Surgery
- Vol. 77 (7) , 1941-1949
Effects of bariatric surgery on hyperuricemia and gout: a systematic review of the literature
- 9 November 2024
- Published by Springer Nature in Updates in Surgery
- Vol. 77 (7) , 1941-1949
Effects of bariatric surgery on hyperuricemia and gout: a systematic review of the literature
- 28 January 2022
- Published by Springer Nature in Obesity Surgery
- Vol. 32 (4) , 1364-1365
Reply to Comment on Sleeve Gastrectomy Versus Roux-en-Y Gastric Bypass in the Elderly: 1-Year Preliminary Outcomes in a Randomized Trial (BASE Trial)
- 28 January 2022
- Published by Springer Nature in Obesity Surgery
- Vol. 32 (4) , 1364-1365
Reply to Comment on Sleeve Gastrectomy Versus Roux-en-Y Gastric Bypass in the Elderly: 1-Year Preliminary Outcomes in a Randomized Trial (BASE Trial)
- 1 August 2021
- Published by Elsevier in Surgery for Obesity and Related Diseases
- Vol. 17 (8) , 1416-1417
Comment on: Sleeve gastrectomy versus Roux-En-Y gastric bypass in patients aged ≥65 years: a comparison of short-term outcomes
- 1 August 2021
- Published by Elsevier in Surgery for Obesity and Related Diseases
- Vol. 17 (8) , 1416-1417
Comment on: Sleeve gastrectomy versus Roux-En-Y gastric bypass in patients aged ≥65 years: a comparison of short-term outcomes
- 26 June 2021
- Published by Springer Nature in Obesity Surgery
- Vol. 31 (11) , 5047-5048
Sleeve Gastrectomy Versus Roux-en-Y Gastric Bypass in the Elderly: 1-Year Preliminary Outcomes in a Randomized Trial (BASE Trial)
- 26 June 2021
- Published by Springer Nature in Obesity Surgery
- Vol. 31 (11) , 5047-5048
Sleeve Gastrectomy Versus Roux-en-Y Gastric Bypass in the Elderly: 1-Year Preliminary Outcomes in a Randomized Trial (BASE Trial)
- 1 September 2020
- Published by Elsevier in Surgery for Obesity and Related Diseases
- Vol. 16 (9) , e53-e54
Comment on: Correlation of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio with metabolic parameters in patients undergoing sleeve gastrectomy
- 1 September 2020
- Published by Elsevier in Surgery for Obesity and Related Diseases
- Vol. 16 (9) , e53-e54
Comment on: Correlation of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio with metabolic parameters in patients undergoing sleeve gastrectomy
- 24 June 2020
- Published by Springer Nature in Obesity Surgery
- Vol. 30 (10) , 4169-4170
Laparoscopic Management of Internal Hernia After One Anastomosis Gastric Bypass (OAGB)
Among the advantages of the One Anastomosis Gastric Bypass (OAGB) are the lack of jejuno-jejunal anastomosis and a supposed lower incidence of internal hernia (IH), with only a few cases reported until now. However, the incidence of IH after OAGB is not null. We present a video of the laparoscopic management of an IH that occurred after an OAGB. The patient was a 49-year-old female who had undergone a laparoscopic revisional OAGB 2 years previously after a failed laparoscopic adjustable gastric banding. She was referred to our Unit for recurrent postprandial colicky pain. She lost a total of 50 kg and her body mass index (BMI) dropped from 38 to 19 kg/m2. A CT scan with intravenous contrast showed a swirl of the mesentery around the superior mesenteric artery, without small bowel obstruction. A laparoscopic exploration was performed, confirming the suspicion of IH at the Petersen’s space. An anticlockwise derotation of the whole common limb was performed, and the Petersen’s space was eventually closed with a running non-absorbable suture.
- 24 June 2020
- Published by Springer Nature in Obesity Surgery
- Vol. 30 (10) , 4169-4170
Laparoscopic Management of Internal Hernia After One Anastomosis Gastric Bypass (OAGB)
Among the advantages of the One Anastomosis Gastric Bypass (OAGB) are the lack of jejuno-jejunal anastomosis and a supposed lower incidence of internal hernia (IH), with only a few cases reported until now. However, the incidence of IH after OAGB is not null. We present a video of the laparoscopic management of an IH that occurred after an OAGB. The patient was a 49-year-old female who had undergone a laparoscopic revisional OAGB 2 years previously after a failed laparoscopic adjustable gastric banding. She was referred to our Unit for recurrent postprandial colicky pain. She lost a total of 50 kg and her body mass index (BMI) dropped from 38 to 19 kg/m2. A CT scan with intravenous contrast showed a swirl of the mesentery around the superior mesenteric artery, without small bowel obstruction. A laparoscopic exploration was performed, confirming the suspicion of IH at the Petersen’s space. An anticlockwise derotation of the whole common limb was performed, and the Petersen’s space was eventually closed with a running non-absorbable suture.
- Open Access
Seminal but not Serum Levels of Holotranscobalamin are Altered in Morbid Obesity and Correlate with Semen Quality: A Pilot Single Centre Study
Vitamin B12 (cobalamin) is an essential cofactor in the one-carbon metabolism. One-carbon metabolism is a set of complex biochemical reactions, through which methyl groups are utilised or generated, and thus plays a vital role to many cellular functions in humans. Low levels of cobalamin have been associated to metabolic/reproductive pathologies. However, cobalamin status has never been investigated in morbid obesity in relation with the reduced semen quality. We analysed the cross-sectional data of 47-morbidly-obese and 21 lean men at Careggi University Hospital and evaluated total cobalamin (CBL) and holotranscobalamin (the active form of B12; holoTC) levels in serum and semen. Both seminal and serum concentrations of holoTC and CBL were lower in morbidly obese compared to lean men, although the difference did not reach any statistical significance for serum holoTC. Seminal CBL and holoTC were significantly higher than serum levels in both groups. Significant positive correlations were observed between seminal holoTC and total sperm motility (r = 0.394, p = 0.012), sperm concentration (r = 0.401, p = 0.009), total sperm number (r = 0.343, p = 0.028), and negative correlation with semen pH (r = −0.535, p = 0.0001). ROC analysis supported seminal holoTC as the best predictor of sperm number (AUC = 0.769 ± 0.08, p = 0.006). Our findings suggest that seminal rather than serum levels of holoTC may represent a good marker of semen quality in morbidly obese subjects.
Open AccessSeminal but not Serum Levels of Holotranscobalamin are Altered in Morbid Obesity and Correlate with Semen Quality: A Pilot Single Centre Study
Vitamin B12 (cobalamin) is an essential cofactor in the one-carbon metabolism. One-carbon metabolism is a set of complex biochemical reactions, through which methyl groups are utilised or generated, and thus plays a vital role to many cellular functions in humans. Low levels of cobalamin have been associated to metabolic/reproductive pathologies. However, cobalamin status has never been investigated in morbid obesity in relation with the reduced semen quality. We analysed the cross-sectional data of 47-morbidly-obese and 21 lean men at Careggi University Hospital and evaluated total cobalamin (CBL) and holotranscobalamin (the active form of B12; holoTC) levels in serum and semen. Both seminal and serum concentrations of holoTC and CBL were lower in morbidly obese compared to lean men, although the difference did not reach any statistical significance for serum holoTC. Seminal CBL and holoTC were significantly higher than serum levels in both groups. Significant positive correlations were observed between seminal holoTC and total sperm motility (r = 0.394, p = 0.012), sperm concentration (r = 0.401, p = 0.009), total sperm number (r = 0.343, p = 0.028), and negative correlation with semen pH (r = −0.535, p = 0.0001). ROC analysis supported seminal holoTC as the best predictor of sperm number (AUC = 0.769 ± 0.08, p = 0.006). Our findings suggest that seminal rather than serum levels of holoTC may represent a good marker of semen quality in morbidly obese subjects.
- 31 January 2019
- Published by Springer Nature in Obesity Surgery
- Vol. 29 (4) , 1368-1369
Reply to “Laparoscopic Conversion of One Anastomosis Gastric Bypass to Roux-en-Y Gastric Bypass”
- 31 January 2019
- Published by Springer Nature in Obesity Surgery
- Vol. 29 (4) , 1368-1369
Reply to “Laparoscopic Conversion of One Anastomosis Gastric Bypass to Roux-en-Y Gastric Bypass”